Loading...

PR Information Data

154 개 7 페이지
번호 컨텐츠
64 REMISSION 1℃ Builds a Bridgehead for Entering Uzbekistan : 2019.11.28 HOT 2019-11-28   5180 (주)아디포랩스
63 AdipoLABs participated in the launching ceremony of GBA (Global Business Alliance): 2019.11.26 HOT 2019-11-26   5438 (주)아디포랩스
62 "AdipoLABs supports MOU between Dae-jeon University's Seoul Oriental Hospital and the United World Halal Development" : 2019.11.22 HOT 2019-11-22   4817 (주)아디포랩스
61 AdipoLABs supported Philippine medical team and Daejeon University Seoul Oriental Medicine Hospital’s meeting: 2019.11.12 HOT 2019-11-12   4927 (주)아디포랩스
60 [CEO &] AdipoLABs and REMISSION 1°C receive special attention on the global stage : 2019.10.28 HOT 2019-10-28   5253 (주)아디포랩스
59 AdipoLABs signs a business agreement with LG Twins : 2019.09.25 HOT 2019-09-25   5032 (주)아디포랩스
58 Principles of hyperthermia high-frequency therapy and cancer treatment... “High-frequency thermal therapy to kill cancer cells with heat has rare side effects" : 2019.03.22 HOT 2019-03-22   6055 (주)아디포랩스
57 AdipoLABs Hosts a Seminar on the Effect of Hyperthermia and Case Report at KIMES 2019 : 2019.03.14 HOT 2019-03-14   5265 (주)아디포랩스
56 AdipoLABs' CEO Han Sung-Ho received the National Assembly's Health and Welfare Commissioner Award at KIMES 2019 : 2019.03.14 HOT 2019-03-14   5359 (주)아디포랩스
55 AdipoLABs receives 'Industrial Grand Prize for 3 consecutive years' : 2019.03.08 HOT 2019-03-08   4967 (주)아디포랩스
54 [KIMES 2019] AdipoLABs to Display 'REMISSION 1℃', High Frequency Hyperthermia Device for Medical Use : 2019.03.08 HOT 2019-03-08   5223 (주)아디포랩스
53 AdipoLABs, attending to ‘Health Tech India’ exhibition.. ’Strengthening entry into Halal market’ : 2019.03.07 HOT 2019-03-07   5395 (주)아디포랩스
52 Challenge the global medical device market with proven clinical effects : 2019.02.01 HOT 2019-02-01   5137 (주)아디포랩스
51 Korea medical cancer treatment device REMISSION 1 ℃ introduced in India : 2019.01.28 HOT 2019-01-28   5083 (주)아디포랩스
50 South Korean CEO Promises Hopeful New Year : 2019.01.02 HOT 2019-01-02   5062 (주)아디포랩스